Scribd
Upload
153 views5 pages

Elevance Health: (Former Anthem Inc)

1) Elevance Health (formerly Anthem Inc.) earns over half its revenue from prescription drug sales through its IngenioRx business, with government programs and commercial insurance making up other large portions. 2) Key drivers of future revenue growth include projections for growth in the health insurance and pharmacy markets, as well as expected increases in government spending on healthcare programs. 3) Financial analysis shows Elevance Health has higher profit margins and return on assets compared to industry averages, positioning it for continued revenue growth in coming years.

Uploaded by

Hans Weirl
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
153 views5 pages

Elevance Health: (Former Anthem Inc)

1) Elevance Health (formerly Anthem Inc.) earns over half its revenue from prescription drug sales through its IngenioRx business, with government programs and commercial insurance making up other large portions. 2) Key drivers of future revenue growth include projections for growth in the health insurance and pharmacy markets, as well as expected increases in government spending on healthcare programs. 3) Financial analysis shows Elevance Health has higher profit margins and return on assets compared to industry averages, positioning it for continued revenue growth in coming years.

Uploaded by

Hans Weirl
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
You are on page 1/ 5

ELEVANCE HEALTH

(FORMER ANTHEM INC)

LASHA CHIKOVANI
GIORGI CHKHATARASHVILI
GIORGI PERTSULIANI
REVENUE STREAMS & DRIVERS
share in revenue for 2021
INSURANCE PREMIUM SOURCE BREAKDOWN:
COMMERCIAL & SPECIALTY 7%

GOVERNMENT BUSINESS 16%


25%

PRESCRIPTION DRUGS RETAIL SALES:


INGENIORX
KEY DRIVERS ANALYZED: 53%

1) HEALTH INSURANCE MARKET PROJECTIONS Commercial & Specialty Business


IngenioRx
Government Business
Other

2) PHARMACIES AND RETAIL DRUG STORES MARKET OUTLOOK


3) GOVERNMENT SPENDING PROJECTIONS PER US CONGRESS PROPOSAL FOR
MEDICARE PROGRAM
4) SECURITIES’ MARKET PROJECTION (APPLICABLE FOR NON-OPERATING
REVENUES)
Insurance market growth rate
14.0%

12.0%
10.6%
12.7%
INSURANCE MARKET
10.2%

TREND AND PROJECTIONS


10.0% 9.1%
8.3%
8.0% 7.1%
6.4%

FOR INGENIORX REVENUE


6.0%

4.0%

2.0% 2.1%

0.0%
2018 2019 2020 2021

Market Anthem Inc

IngenioRx arm revenue


$40,000

$35,000 $34,148
$32,301
$30,554
$30,000 $28,902
$27,338
$25,431
$25,000
$21,911
$20,000

$15,000

$10,000
$5,402
$5,000

$-
2019 2020 2021 E2022 E2023 E2024 E2025 E2026
25.0

KEY METRICS 20.0

15.0

10.0

5.0

0.0
EV/Ebitda P/E

Anthem Industy

Anthem CVS Aetna Industy


ROA 8.2% 6.94% 7.04%
Profit Margin 5.5% 6.41% 3.80%
Current Ratio 1.47 1.55 1.87
EV/Ebitda 12.8 9.5 9.2
P/E 19.6 17.4 21.2
ENTERPRISE VALUE

  Quote Stock price Market Cap


Anthem ELV $ 486.00 $ 117,160.00
CVS Aetna CVS $ 93.94 $ 123,180.00
       
Anthem EV per Industry EV/EBITDA $ 84,125.52 $ (33,034.48)
anthem EBITDA   9164
Industry Multiple   9.18
       
Anthem EV per Industry P/E   $ 129,404.80 $ 12,244.80
Anthem earnings   6,104.00
Industry P/E   21.20

You might also like